Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. IDEXX Laboratories, Inc.
  6. News
  7. Summary
    IDXX   US45168D1046

IDEXX LABORATORIES, INC.

(IDXX)
  Report
Delayed Nasdaq  -  05/18 04:00:01 pm EDT
357.33 USD   -2.46%
05/18IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
PR
05/13IDEXX LABORATORIES INC /DE : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/05JPMorgan Adjusts Price Target for IDEXX Laboratories to $625 From $725, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Sell: Idexx Laboratories

11/10/2021 | 05:38pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about IDEXX LABORATORIES, INC.
05/18IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
PR
05/13IDEXX LABORATORIES INC /DE : Submission of Matters to a Vote of Security Holders (form 8-K..
AQ
05/05JPMorgan Adjusts Price Target for IDEXX Laboratories to $625 From $725, Maintains Overw..
MT
05/05Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $603 from $732, Keeps Overwe..
MT
05/05BofA Securities Downgrades IDEXX Laboratories to Neutral From Buy, Adjusts Price Target..
MT
05/04IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
05/04SECTOR UPDATE : Health Care Stocks Climb Pre-Bell Wednesday
MT
05/04TRANSCRIPT : IDEXX Laboratories, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04IDEXX Laboratories Q1 Earnings Slide, Revenue Rises; Company Lowers 2022 Outlook
MT
05/04IDEXX : Q1 Earnings Snapshot
AQ
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 447 M - -
Net income 2022 721 M - -
Net Debt 2022 817 M - -
P/E ratio 2022 42,5x
Yield 2022 -
Capitalization 30 018 M 30 018 M -
EV / Sales 2022 8,95x
EV / Sales 2023 7,99x
Nbr of Employees 10 350
Free-Float 77,9%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 357,33 $
Average target price 541,13 $
Spread / Average Target 51,4%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-45.73%30 018
ABBOTT LABORATORIES-19.89%197 401
MEDTRONIC PLC0.12%138 943
STRYKER CORPORATION-13.17%87 811
BECTON, DICKINSON AND COMPANY2.17%71 580
HOYA CORPORATION-25.01%36 535